Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
RLN2
REST API REST API
Homo sapiens
RLN2 is differentially expressed in 210 experiments: 67 organism parts: prostate, mammary gland, ... (65 more);, 74 disease states: normal, prostate carcinoma, ... (72 more);, 57 cell types 257 cell lines 22 compound treatments and 64 other conditions.
Synonyms H2, RLXH2, bA12D24.1.2, bA12D24.1.1
Orthologs Rln1 (Mus musculus)   Rln1 (Rattus norvegicus)   RELX_CANFA (Canis familiaris)   (Compare orthologs)
InterPro Term Insulin_family, Insulin-like, Relaxin
Gene Ontology Term extracellular region, hormone activity, female pregnancy
UniProt Accession A6PVK6, P04090
Search EB-eye ENSG00000107014
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-GEOD-22541, E-MTAB-24, ... (22 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, E-GEOD-18005, ... (39 experiments)

Factor Value U/D Experiments
SW480
1
3
E-MEXP-1014, E-MTAB-37, E-GEOD-18005, E-GEOD-2509
CCRFCEM
2
E-GEOD-24147, E-MTAB-37
HCC38
2
E-MTAB-37, E-MTAB-62
LNCaP
2
E-GEOD-14990, E-GEOD-762
MCF-10A
2
E-TABM-420, E-GEOD-14990
MCF-7
2
E-GEOD-19639, E-GEOD-20081
251 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-3920, E-GEOD-20677, E-GEOD-13909, E-GEOD-13987, ... (31 experiments)

Factor Value U/D Experiments
macrophage
2
E-GEOD-3982, E-GEOD-8286
2
E-TABM-145, E-TABM-130
intrathymic T progenitor cell
1
E-GEOD-1460
ovarian cancer
1
E-GEOD-21154
LCC
1
E-GEOD-19188
CD8+CD28+
1
E-MEXP-2345
51 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-MEXP-2069, E-GEOD-9692, ... (33 experiments)

Factor Value U/D Experiments
prostate carcinoma
1
3
E-MTAB-62, E-GEOD-7307, E-MEXP-2034, E-MTAB-37
tumor
1
E-GEOD-19188
cystic fibrosis
1
E-MTAB-62
glioblastoma
1
E-GEOD-4290
clear cell sarcoma of the kidney
1
E-GEOD-2712
benign nevus
1
E-GEOD-3189
68 more value(s).


Compound treatment

studied in E-GEOD-1615, E-GEOD-7400, E-GEOD-5824, E-GEOD-3720, E-GEOD-6462, ... (15 experiments)

Factor Value U/D Experiments
control
2
E-GEOD-3284, E-GEOD-4006
none
2
3
E-GEOD-412, E-GEOD-5824, E-GEOD-1615, E-GEOD-7400, E-GEOD-2803 ... (5 experiments)
granulocyte macrophage-colony stimulating factor
1
E-GEOD-2803
CNOT7+CNOT8
1
E-MEXP-2218
NaOH
1
E-MEXP-2590
control for EGF
1
E-GEOD-6462
16 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


Biopsy tissue
studied in E-GEOD-5851

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-2034, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-5999, E-GEOD-20033, E-MEXP-2359, E-GEOD-2666, E-GEOD-4667 ... (5 experiments)

Dfs follow up
studied in E-GEOD-22541

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-1323, E-GEOD-19743, E-GEOD-3325, E-GEOD-2509, E-TABM-147, ... (7 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-21589, E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482, E-GEOD-17385, E-MTAB-108

Genotype
studied in E-GEOD-3494, E-TABM-601, E-MEXP-1838, E-GEOD-17347

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-GEOD-7011, E-MEXP-1103, E-MEXP-2146 ... (5 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Her2 status
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-16194, E-GEOD-20194, E-GEOD-16716

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-740, E-GEOD-1926, E-MEXP-2069, ... (28 experiments)

Infection
studied in E-GEOD-980, E-GEOD-17400

Initial distant metastases
studied in E-GEOD-22541

Injury
studied in E-GEOD-19743

Irradiate
studied in E-GEOD-1977

Karyotype
studied in E-GEOD-7214

Light
studied in E-GEOD-1725

Localisation of metastases
studied in E-GEOD-22541

Material type
studied in E-MEXP-455

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Organism
studied in E-GEOD-7540

Performer
studied in E-GEOD-2004, E-LGCL-5

Phase
studied in E-GEOD-4888

Progesterone receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246

Qrt pcr areg dct
studied in E-GEOD-5851

RNAi
studied in E-GEOD-12438, E-GEOD-1676, E-MEXP-101, E-GEOD-3697, E-MEXP-1857, ... (6 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-22541, E-GEOD-7307

Sirna
studied in E-GEOD-21574

Stimulation
studied in E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-19246, E-GEOD-13818, E-GEOD-12198

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-3494, E-GEOD-22541, E-TABM-43, E-GEOD-1561, E-GEOD-4922 ... (5 experiments)

Vehicle
studied in E-GEOD-5258

Processing time: 0.35 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM